Sertraline Hydrochloride NDC 70710-1948

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-1948Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-1948Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-1948-3	70710194803	30 CAPSULE in 1 BOTTLE (70710-1948-3)Marketed from Jan 29, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sertraline Hydrochloride
Generic name (nonproprietary): sertraline hydrochloride
Active ingredients: Sertraline hydrochloride — 150 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Zydus Pharmaceuticals (USA) Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 220275
Marketing start: Jan 29, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2D6 Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 70710-1948_55c2a9d1-6c98-4073-8532-b1f51aa2fda9SPL ID 55c2a9d1-6c98-4073-8532-b1f51aa2fda9SPL set ID 23f1c8c5-032c-4ea9-beb0-ca3a614ba4b6RxCUI 251201, 410584UNII UTI8907Y6X
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470710194803 followed by a unit qualifier and the quantity

Package 70710-1948-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 26, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Sertraline hydrochloride capsules are indicated for the treatment of the following [see Clinical Studies ( 14 )] : Major depressive disorder (MDD) in adults Obsessive-compulsive disorder (OCD) in adults and pediatric patients 6 years and older Sertraline hydrochloride capsules are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of ( 1 ): Major depressive disorder (MDD) in adults Obsessive-compulsive disorder (OCD) in adults and pediatric patients 6 years and older

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 220275

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 220275
Product	Strength	Form · route	Labeler	Product NDC
Sertraline Hydrochloride	Sertraline hydrochloride 200 mg/1	CapsuleOral	Zydus Pharmaceuticals (USA) Inc.	70710-1949
Sertraline Hydrochloride	Sertraline hydrochloride 200 mg/1	CapsuleOral	Zydus Lifesciences Limited	70771-1914
Sertraline Hydrochloride	Sertraline hydrochloride 150 mg/1	CapsuleOral	Zydus Lifesciences Limited	70771-1913